Literature DB >> 10640593

Effect of formulation and process variables on porosity parameters and release rates from a multi unit erosion matrix of a poorly soluble drug.

K A Mehta1, M S Kislalioglu, W Phuapradit, A W Malick, N H Shah.   

Abstract

The effect of drug loading, water required for granulation and spheronization time on porosity parameters (intrusion-extrusion isotherms, pore size distribution, total pore surface area, mean pore diameter, shape and morphology of pores) and drug release rates from pellets of a poorly soluble drug was investigated. Porosity parameters were determined by mercury intrusion porosimetry. The drug loading was found to have a profound effect on the porosity parameters. Pellets with low drug loading showed increased pore surface area with small mean pore diameters and an increased number of total pores. On the other hand, pellets with high drug loading had decreased pore surface areas with larger mean pore diameters and a reduction in the total number of pores. With high drug loading, the drug release rate decreased. Water required for granulation had a direct effect on the total porosity of the pellets. Spheronization time from 2 to 10 min had a pronounced effect on porosity parameters and release rates. No changes in porosity parameters and release rates were observed from 10 to 20 min of spheronization time. It was shown that each porosity parameter investigated was well correlated with drug release rates and thus it is important to study the effect of porosity parameters in evaluating the in vitro performance of the multi-unit erosion matrix for the controlled release of a poorly soluble drug.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10640593     DOI: 10.1016/s0168-3659(99)00193-5

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  7 in total

1.  Influence of operational variables on properties of piroxicam pellets prepared by extrusion-spheronization: a technical note.

Authors:  Vivek R Sinha; Manoj K Agrawal; Rachna Kumria; Jayant R Bhinge
Journal:  AAPS PharmSciTech       Date:  2007-03-09       Impact factor: 3.246

2.  In vitro, ex vivo and in silico mechanistic elucidation of the performance of an optimized porosity-controlled multi-elemental transbuccal system.

Authors:  Oluwatoyin A Adeleke; Yahya E Choonara; Lisa C du Toit; Pradeep Kumar; Viness Pillay
Journal:  Pharm Res       Date:  2015-01-29       Impact factor: 4.200

3.  A Novel Approach for Analyzing the Dissolution Mechanism of Solid Dispersions.

Authors:  Yuanhui Ji; Raphael Paus; Anke Prudic; Christian Lübbert; Gabriele Sadowski
Journal:  Pharm Res       Date:  2015-02-27       Impact factor: 4.200

4.  Ibuprofen-loaded calcium stearate pellets: drying-induced variations in dosage form properties.

Authors:  Simone Schrank; Aden Hodzic; Andreas Zimmer; Benjamin J Glasser; Johannes Khinast; Eva Roblegg
Journal:  AAPS PharmSciTech       Date:  2012-05-03       Impact factor: 3.246

5.  Release behaviour of single pellets and internal fine 3D structural features co-define the in vitro drug release profile.

Authors:  Shuo Yang; Xianzhen Yin; Caifen Wang; Haiyan Li; You He; Tiqiao Xiao; Lixin Sun; Jiasheng Li; Peter York; Jun He; Jiwen Zhang
Journal:  AAPS J       Date:  2014-05-30       Impact factor: 4.009

6.  Drug-Polymers Composite Matrix Tablets: Effect of Hydroxypropyl Methylcellulose (HPMC) K-Series on Porosity, Compatibility, and Release Behavior of the Tablet Containing a BCS Class I Drug.

Authors:  Namon Hirun; Pakorn Kraisit
Journal:  Polymers (Basel)       Date:  2022-08-19       Impact factor: 4.967

7.  QbD based Eudragit coated Meclizine HCl immediate and extended release multiparticulates: formulation, characterization and pharmacokinetic evaluation using HPLC-Fluorescence detection method.

Authors:  Faaiza Qazi; Muhammad Harris Shoaib; Rabia Ismail Yousuf; Fahad Siddiqui; Muhammad Iqbal Nasiri; Kamran Ahmed; Iyad Naeem Muhammad; Farrukh Rafiq Ahmed
Journal:  Sci Rep       Date:  2020-09-10       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.